These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31335392)

  • 21. Review of precision cancer medicine: Evolution of the treatment paradigm.
    Tsimberidou AM; Fountzilas E; Nikanjam M; Kurzrock R
    Cancer Treat Rev; 2020 Jun; 86():102019. PubMed ID: 32251926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
    Do K; O'Sullivan Coyne G; Chen AP
    Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementing Precision Medicine Programs and Clinical Trials in the Community-Based Oncology Practice: Barriers and Best Practices.
    Ersek JL; Black LJ; Thompson MA; Kim ES
    Am Soc Clin Oncol Educ Book; 2018 May; 38():188-196. PubMed ID: 30231363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Light and shadow on innovative clinical trial designs: reflections from the EORTC-PAMM course on 'preclinical and early-phase clinical pharmacology'.
    Leonetti A; Boyd L; Giuliani J; Giovannetti E; Garajová I
    Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1033-1036. PubMed ID: 31633383
    [No Abstract]   [Full Text] [Related]  

  • 25. Variance prior specification for a basket trial design using Bayesian hierarchical modeling.
    Cunanan KM; Iasonos A; Shen R; Gönen M
    Clin Trials; 2019 Apr; 16(2):142-153. PubMed ID: 30526008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine.
    Tsimberidou AM; Ringborg U; Schilsky RL
    Am Soc Clin Oncol Educ Book; 2013; ():118-25. PubMed ID: 23714475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Study Designs in Precision Medicine - Basket, Umbrella and Platform Trials.
    Ravi R; Kesari HV
    Curr Rev Clin Exp Pharmacol; 2022; 17(2):114-121. PubMed ID: 34455953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses.
    Tsimberidou AM; Wen S; Hong DS; Wheler JJ; Falchook GS; Fu S; Piha-Paul S; Naing A; Janku F; Aldape K; Ye Y; Kurzrock R; Berry D
    Clin Cancer Res; 2014 Sep; 20(18):4827-36. PubMed ID: 24987059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Host-dependent variables: The missing link to personalized medicine.
    Demlova R; Zdrazilova-Dubska L; Sterba J; Stanta G; Valik D
    Eur J Surg Oncol; 2018 Sep; 44(9):1289-1294. PubMed ID: 29735363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Advancements and Innovations in Pediatric Precision Oncology.
    Mangum R; Lin FY; Parsons DW
    J Pediatr Hematol Oncol; 2024 Jul; 46(5):262-271. PubMed ID: 38857189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Art and Challenges of Precision Medicine: Interpreting and Integrating Genomic Data Into Clinical Practice.
    Madhavan S; Subramaniam S; Brown TD; Chen JL
    Am Soc Clin Oncol Educ Book; 2018 May; 38():546-553. PubMed ID: 30231369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Precision oncology and molecular tumor boards].
    Mack E; Horak P; Fröhling S; Neubauer A
    Inn Med (Heidelb); 2024 May; 65(5):462-471. PubMed ID: 38652307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Challenges of Precision Oncology Drug Development and Implementation.
    Hollingsworth SJ; Biankin AV
    Public Health Genomics; 2015; 18(6):338-48. PubMed ID: 26555355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
    Arnall JR; Petro R; Patel JN; Kennedy L
    J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
    Nadauld LD; Ford JM; Pritchard D; Brown T
    Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine.
    Tsimberidou AM; Hong DS; Wheler JJ; Falchook GS; Janku F; Naing A; Fu S; Piha-Paul S; Cartwright C; Broaddus RR; Nogueras Gonzalez GM; Hwu P; Kurzrock R
    J Hematol Oncol; 2019 Dec; 12(1):145. PubMed ID: 31888672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
    Schmidt KT; Chau CH; Price DK; Figg WD
    J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precision Medicine in Gastrointestinal Pathology.
    Wang DH; Park JY
    Arch Pathol Lab Med; 2016 May; 140(5):449-60. PubMed ID: 27128302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obstacles to precision oncology: confronting current factors affecting the successful introduction of biomarkers to the clinic.
    Prudkin L; Nuciforo P
    Cell Oncol (Dordr); 2015 Feb; 38(1):39-48. PubMed ID: 25185990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonotyping for precision oncology.
    Dang HX; Maher CA
    Drug Discov Today; 2015 Dec; 20(12):1464-9. PubMed ID: 26494143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.